Tags

Type your tag names separated by a space and hit enter

Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors.
Immunopharmacology 2000; 47(2-3):127-62I

Links

  • Publisher Full Text

    • Authors+Show Affiliations

    Souness JE
    Discovery Biology 1 (JA3-1), Aventis Pharma Ltd., Dagenham Research Centre, Rainham Road South, Dagenham, RM10 7XS, Essex, UK. john.souness@aventis.com
    Aldous D
    No affiliation info available
    Sargent C
    No affiliation info available

    MeSH

    3',5'-Cyclic-AMP PhosphodiesterasesAnimalsAnti-Inflammatory AgentsAutoimmune DiseasesCyclic Nucleotide Phosphodiesterases, Type 4Cyclohexanecarboxylic AcidsDermatologic AgentsHumansLung DiseasesNitrilesPhosphodiesterase Inhibitors

    Pub Type(s)

    Journal Article
    Review

    Language

    eng

    PubMed ID

    10878287

    Citation

    Souness, J E., et al. "Immunosuppressive and Anti-inflammatory Effects of Cyclic AMP Phosphodiesterase (PDE) Type 4 Inhibitors." Immunopharmacology, vol. 47, no. 2-3, 2000, pp. 127-62.
    Souness JE, Aldous D, Sargent C. Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors. Immunopharmacology. 2000;47(2-3):127-62.
    Souness, J. E., Aldous, D., & Sargent, C. (2000). Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors. Immunopharmacology, 47(2-3), pp. 127-62.
    Souness JE, Aldous D, Sargent C. Immunosuppressive and Anti-inflammatory Effects of Cyclic AMP Phosphodiesterase (PDE) Type 4 Inhibitors. Immunopharmacology. 2000;47(2-3):127-62. PubMed PMID: 10878287.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors. AU - Souness,J E, AU - Aldous,D, AU - Sargent,C, PY - 2000/7/6/pubmed PY - 2000/9/9/medline PY - 2000/7/6/entrez SP - 127 EP - 62 JF - Immunopharmacology JO - Immunopharmacology VL - 47 IS - 2-3 SN - 0162-3109 UR - https://www.unboundmedicine.com/medline/citation/10878287/ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0162310900001855 DB - PRIME DP - Unbound Medicine ER -